A Physiologically Based Pharmacokinetic Model for Acrylamide and Its Metabolite, Glycidamide, in the Rat

By Kirman Christopher   Gargas Michael   Deskin Randy   Tonner-Navarro Lisa   Andersen Melvin  

Journal of Toxicology and Environmental Health, Vol. 66, Iss. 3, 2003-01 ,pp. : 253-274

Taylor & Francis Ltd

Access to resources Recommend Favorite

Population pharmacokinetic modeling of motesanib and its active metabolite, M4, in cancer patients

By  

Clinical Pharmacology In Drug Development, Vol. 4, Iss. 6, 2015-11 ,pp. : 463-472

John Wiley & Sons Inc

Access to resources Recommend Favorite

Population Pharmacokinetics of Cycloplatam. I. Development of the Population Model for Description of the Pharmacokinetic and Pharmacodynamic Processes Involving Cycloplatam

By Singin A. S.  

Pharmaceutical Chemistry Journal, Vol. 37, Iss. 10, 2003-10 ,pp. : 513-517

Springer Publishing Company

Access to resources Recommend Favorite

A Mechanism-Based Population Pharmacokinetic Model for Characterizing Time-Dependent Pharmacokinetics of Midostaurin and its Metabolites in Human Subjects

By Yin Ophelia Q.P.   Wang Yanfeng   Schran Horst  

Clinical Pharmacokinetics, Vol. 47, Iss. 12, 2008-01 ,pp. : 807-816

Adis International

Access to resources Recommend Favorite

Predictive Performance of a Recently Developed Population Pharmacokinetic Model for Morphine and its Metabolites in New Datasets of (Preterm) Neonates, Infants and Children

By Krekels Elke H.J.   DeJongh Joost   van Lingen Richard A.  

Clinical Pharmacokinetics, Vol. 50, Iss. 1, 2011-01 ,pp. : 51-63

Adis International

Access to resources Recommend Favorite